锚定多重PCR融合检测在软组织肿瘤细胞学诊断中的应用
本研究评估了锚定多重PCR基因融合检测在软组织肿瘤细胞学标本中的可行性。在1609例细胞学标本中,48例(3%)为间叶肿瘤,其中14例(29%)检测到可报告的融合转录本,8例融合为疾病定义性,6例为转移灶分子确认。该检测在多数病例中可获得足够质量和数量的组织。
要点
- 细胞学标本中间叶肿瘤占比低(3%),但锚定多重PCR融合检测可行。
- 48例中间叶肿瘤29%检出可报告融合,67%无融合,4%组织不足。
- 检出融合的14例中8例为疾病定义性,6例确认转移灶。
核心结论
- 锚定多重PCR基因融合检测是辅助细胞学标本中间叶肿瘤诊断的有力正交工具。
研究设计与样本
- 回顾性研究,查询实验室信息系统,纳入1609例接受锚定多重PCR检测的细胞学标本,排除上皮和血液淋巴肿瘤后分析48例间叶肿瘤。
主要发现
- 48例间叶肿瘤细胞学标本中,14例(29%)锚定多重PCR检出可报告融合转录本。
- 32例(67%)未检测到融合,2例(4%)组织不足无法分析。
- 可检测的融合伴侣包括ALK(n=4)、STAT6(n=4)、EWSR1(n=3),以及SS18、YAP1、PHF1各1例。
- 14例融合阳性中,8例在细胞学制备上为疾病定义性,6例为既往诊断肿瘤转移灶的分子确认。
临床怎么用
- 对细胞学标本中间叶肿瘤可考虑行锚定多重PCR融合检测以辅助诊断。
- 多数细胞学标本可提供足够质量/数量的组织用于该检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fine-needle aspiration specimens from soft tissue tumors are complicated by lack of tissue architecture and limited material for ancillary testing. There are little data on the feasibility of next-generation sequencing techniques for fusion detection on soft tissue cytology specimens. This study explored the role of an anchored multiplex polymerase chain reaction (PCR)-based gene fusion assay in aiding the diagnosis of mesenchymal neoplasms on cytology samples. METHODS: The laboratory information system was queried for cytology specimens that had undergone testing by anchored multiplex PCR. After exclusion of epithelial and hematolymphoid neoplasms, clinical and pathologic information was collected on the remaining cases. RESULTS: There were 1609 cytology specimens tested with anchored multiplex PCR. Of these, 48 (3%) were cytology specimens from mesenchymal tumors. Anchored multiplex PCR was positive for a reportable fusion transcript in 14 of 48 cases (29%); there was no fusion detected in 32 cases (67%), and there was insufficient tissue for analysis in two cases (4%). The detectable fusion partners included ALK (n = 4), STAT6 (n = 4), EWSR1 (n = 3), and one each of SS18, YAP1, and PHF1. Of the cases in which a fusion partner was detected, eight of 14 were disease-defining on cytology preparation, and six of 14 provided molecular confirmation of a metastatic focus of a previously diagnosed tumor. CONCLUSIONS: The anchored, multiplex PCR-based gene fusion assay is a powerful orthogonal tool in helping diagnose mesenchymal neoplasms on cytology specimens. The material obtained for cytologic analysis yields sufficient quality/quantity of tissue in the majority of cases tested.
引用
- Helland TL, Fisch AS, Chebib I, et al. Utility of an anchored multiplex polymerase chain reaction-based fusion assay for diagnosis of soft tissue tumors in cytology. Cancer Cytopathol. 2024. PMID: 38944697. doi:10.1002/cncy.22881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。